Feature|Articles|September 15, 2026

Pharma Now Has Two Audiences — People and Machines: Q&A with Stewart Gandolf

Pharma brands with all the right information are still invisible to AI — and why silence is the bigger risk than inaccuracy.

AI became the most common way people search the internet. Not surprisingly, the new technology impacted that way that people search, including patients. Now, instead of keyword searching, many experts are saying that people search by question.

Related to this article

Pharmaceutical Executive Daily
FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing site for next-generation obesity treatments, and Parexel’s Stacy Hurt on how small protocol decisions can become enrollment and retention barriers.